CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death ...
AstraZeneca’s logo is mounted to a wall of wooden slats. AstraZeneca’s logo at the company’s Discovery Centre in Cambridge, England Credit: Anthony Devlin/Getty Images for AstraZeneca The UK ...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of ...
LONDON, May 11 (Reuters) - AstraZeneca Plc's experimental heart drug Brilinta has beaten Sanofi-Aventis SA and Bristol-Myers Squibb Co's blockbuster Plavix in a pivotal clinical trial, lifting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results